Santiago-Raber ML - Search Results

1

STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity.

Rossi M, Carboni S, Di Berardino-Besson W, Riva E, Santiago-Raber ML, Belnoue E, Derouazi M. Rossi M, et al. Among authors: santiago raber ml. Front Immunol. 2021 Jul 1;12:695056. doi: 10.3389/fimmu.2021.695056. eCollection 2021. Front Immunol. 2021. PMID: 34276686 Free PMC article.

2

Extended Freeze-Dried BCG Instructed pDCs Induce Suppressive Tregs and Dampen EAE.

Lippens C, Garnier L, Guyonvarc'h PM, Santiago-Raber ML, Hugues S. Lippens C, et al. Among authors: santiago raber ml. Front Immunol. 2018 Nov 29;9:2777. doi: 10.3389/fimmu.2018.02777. eCollection 2018. Front Immunol. 2018. PMID: 30555468 Free PMC article.

3

Targeting self and neo-epitopes with a modular self-adjuvanting cancer vaccine.

Belnoue E, Mayol JF, Carboni S, Di Berardino Besson W, Dupuychaffray E, Nelde A, Stevanovic S, Santiago-Raber ML, Walker PR, Derouazi M. Belnoue E, et al. Among authors: santiago raber ml. JCI Insight. 2019 Apr 23;5(11):e127305. doi: 10.1172/jci.insight.127305. JCI Insight. 2019. PMID: 31013258 Free PMC article.

4

Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect.

Hofer T, Rossi M, Carboni S, Di Berardino Besson W, von Laer D, Wollmann G, Derouazi M, Santiago-Raber ML. Hofer T, et al. Among authors: santiago raber ml. Cancers (Basel). 2021 Dec 3;13(23):6107. doi: 10.3390/cancers13236107. Cancers (Basel). 2021. PMID: 34885215 Free PMC article.

5

ATP128 Clinical Therapeutic Cancer Vaccine Activates NF-κB and IRF3 Pathways through TLR4 and TLR2 in Human Monocytes and Dendritic Cells.

Pascolutti R, Yeturu L, Philippin G, Costa Borges S, Dejob M, Santiago-Raber ML, Derouazi M. Pascolutti R, et al. Among authors: santiago raber ml. Cancers (Basel). 2022 Oct 20;14(20):5134. doi: 10.3390/cancers14205134. Cancers (Basel). 2022. PMID: 36291919 Free PMC article.

6

Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.

Santiago-Raber ML, Haraldsson MK, Theofilopoulos AN, Kono DH. Santiago-Raber ML, et al. J Immunol. 2007 Jun 15;178(12):8195-202. doi: 10.4049/jimmunol.178.12.8195. J Immunol. 2007. PMID: 17548658

7

Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.

Borel P, Benkhoucha M, Weber MS, Zamvil SS, Santiago-Raber ML, Lalive PH. Borel P, et al. Int Immunol. 2008 Oct;20(10):1313-9. doi: 10.1093/intimm/dxn086. Epub 2008 Aug 6. Int Immunol. 2008. PMID: 18687587

8

Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism.

Tran NL, Manzin-Lorenzi C, Santiago-Raber ML. Tran NL, et al. Among authors: santiago raber ml. Immunology. 2015 May;145(1):60-70. doi: 10.1111/imm.12426. Immunology. 2015. PMID: 25424423 Free PMC article.

9

Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells.

Benkhoucha M, Santiago-Raber ML, Schneiter G, Chofflon M, Funakoshi H, Nakamura T, Lalive PH. Benkhoucha M, et al. Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6424-9. doi: 10.1073/pnas.0912437107. Epub 2010 Mar 23. Proc Natl Acad Sci U S A. 2010. PMID: 20332205 Free PMC article.

10

Selective APRIL blockade delays systemic lupus erythematosus in mouse.

Huard B, Tran NL, Benkhoucha M, Manzin-Lorenzi C, Santiago-Raber ML. Huard B, et al. PLoS One. 2012;7(2):e31837. doi: 10.1371/journal.pone.0031837. Epub 2012 Feb 15. PLoS One. 2012. PMID: 22355399 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page